Home   >  
Neuro Signaling Pathway

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Naproxen sodium Chemical Structure
BCP23430 Naproxen sodium 26159-34-2
Naproxen sodium is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively.
20(S)-Ginsenoside C-K Chemical Structure
BCP30926 20(S)-Ginsenoside C-K 39262-14-1
Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively.
Mofezolac Chemical Structure
BCP30846 Mofezolac 78967-07-4
Mofezolac, also known as Disopain and N-22, is a cyclooxygenase-1 selective inhibitor used to treat pain, musculoskeletal pain, and arthritis.
Ginsenoside-Rg5 Chemical Structure
BCP10278 Ginsenoside-Rg5 186763-78-0
Ginsenoside Rg5 is a triterpenoid saponin. It has a role as a metabolite.
Flunoxaprofen Chemical Structure
BCP30327 Flunoxaprofen 66934-18-7
Flunoxaprofen is a chiral nonsteroidal anti-inflammatory drug (NSAID) that is closely related to naproxen. Flunoxaprofen has been shown to significantly improve the symptoms of osteoarthritis and rheumatoid arthritis.
Amtolmetin guacil Chemical Structure
BCP28767 Amtolmetin guacil 87344-06-7
Amtolmetin guacil is a N-acyl-amino acid.
Dipyrone sodium hydrate Chemical Structure
BCP11981 Dipyrone sodium hydrate 5907-38-0
Dipyrone sodium hydrate is a potent analgesic drug that has been demonstrated to inhibit cyclooxygenase (COX).
Diclofenac Chemical Structure
BCP09087 Diclofenac 15307-86-5
Diclofenac is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 nM, 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1, 0.84 μM for ovine COX-1 and COX-2, respectively.
Mavacoxib Chemical Structure
BCP15454 Mavacoxib 170569-88-7
Mavacoxib is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease. It acts as a COX-2 inhibitor.
Aspirin DL-lysine Chemical Structure
BCP12010 Aspirin DL-lysine 62952-06-1
Aspirin DL-lysine is a non-steroidal anti-inflammatory drug (NSAIDs) that may inhibit cancer growth. Aspirin DL-lysine is a water soluble, injectable aspirin derivative. It is an analgesic; antipyretic; anti-inflammatory.
123下一页末页共 50 条记录 1 / 5 页